Shopping Cart
- Remove All
- Your shopping cart is currently empty
Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $579 | In Stock | |
10 mg | $928 | In Stock | |
25 mg | $1,370 | In Stock | |
50 mg | $1,850 | In Stock |
Description | Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer. |
In vitro | Edrecolomab significantly inhibited the growth of human colon cancer HT-29 tumors. [1] |
In vivo | Edrecolomab (30μg /dose, intravenous) treatment inhibited tumor growth in nude mouse models of HT-29. [1] |
Alias | Panorex, M-17-1A, CO17-1A, CO171A, 17-1A, 1083 17-1A |
Cas No. | 156586-89-9 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.